合成路线1
该中间体在本合成路线中的序号:
(I) By condensation of 5-methoxyindole (I) with 4-piperidone (II) in acetic acid at 100 C, followed by neutralization with succinic acid (A).
【1】
Dumont, C.; et al. (Aventis Pharma SA); Treating psychic disorders with piperidylindoles. ES 461875; FR 2362628; GB 1556919; JP 53028178; US 4196209 .
|
【2】
Serradell, M.N.; Castaner, J.; Blancafort, P.; Paton, D.M.; RU-24,969. Drugs Fut 1981, 6, 3, 157.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
37420 |
succinic acid
|
110-15-6 |
C4H6O4 |
详情 | 详情
|
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
27115 |
4-piperidinone
|
40064-34-4 |
C5H9NO |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) A new synthesis of roxindole has been described: The condensation of 5-methoxyindole (I) with succinic anhydride (II) by means of methylmagnesium bromide in hot anisole gives the 4-oxobutyric acid derivative (III), which is condensed with the 4-phenyltetrahydropyridine (IV) by means of EDC and DIPEA in DMF yielding the butanedione (V). The reduction of (V) with LiAlH4 in refluxing THF affords intermediate (VI), which is finally demethylated with DIBAH in refluxing toluene.
【1】
Lange, J.H.M.; et al.; A straightforward synthetic approach for roxindole. Bioorg Med Chem Lett 1999, 9, 7, 1055.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
11291 |
Dihydro-2,5-furandione; Succinic anhydride
|
108-30-5 |
C4H4O3 |
详情 | 详情
|
(III) |
30614 |
4-(5-methoxy-1H-indol-3-yl)-4-oxobutyric acid
|
|
C13H13NO4 |
详情 |
详情
|
(IV) |
13002 |
4-Phenyl-1,2,3,6-tetrahydropyridine; 1,2,3,6-Tetrahydro-4-phenyl-pyridine
|
10338-69-9 |
C11H13N |
详情 | 详情
|
(V) |
30615 |
1-(5-methoxy-1H-indol-3-yl)-4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]-1,4-butanedione
|
|
C24H24N2O3 |
详情 |
详情
|
(VI) |
12999 |
5-Methoxy-3-[4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butyl]-1H-indole; Methyl 3-[4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butyl]-1H-indol-5-yl ether
|
|
C24H28N2O |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(III) The title compound has been prepared by two related procedures. Treatment of N-carbobenzoxy-D-proline (I) with oxalyl chloride provided the corresponding acid chloride (II). This was condensed with 5-methoxyindolyl magnesium bromide, generated from 5-methoxyindole (III) and ethylmagnesium bromide, to afford the indolyl ketone (IV). Reduction of both keto and carbamate groups of (IV) by means of LiAlH4 in refluxing THF then furnished the target compound.
【1】
Schmidt, A.W.; Macor, J.E.; Blake, J.; Ryan, K.; Fox, C.B.; Zorn, S.H.; Morrone, J.M.; Koe, B.K.; Johnson, C.; Schulz, D.W.; Lebel, L.A.; Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: Discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin. J Med Chem 1992, 35, 23, 4503. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17005 |
(2R)-1-[(benzyloxy)carbonyl]tetrahydro-1H-pyrrole-2-carboxylic acid
|
|
C13H15NO4 |
详情 |
详情
|
(II) |
17006 |
benzyl (2R)-2-(chlorocarbonyl)tetrahydro-1H-pyrrole-1-carboxylate
|
|
C13H14ClNO3 |
详情 |
详情
|
(III) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(IV) |
31540 |
benzyl (2R)-2-[(5-methoxy-1H-indol-3-yl)carbonyl]-1-pyrrolidinecarboxylate
|
|
C22H22N2O4 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(III) Alternatively, 5-methoxyindole (III) was N-silylated employing tert-butyldimethylsilyl chloride and n-BuLi, and the resulting silyl derivative (V) was brominated with N-bromosuccinimide at -78 C to afford the 3-bromoindole (VI). After lithium-bromine exchange in (VI) with n-BuLi at -78 C, the 3-lithio compound was condensed with N-methyl-D-proline methyl ester (VII) to give the indolyl ketone (VIII). The ketone function of (VIII) was finally reduced employing LiAlH4 in boiling THF.
【1】
Qandil, A.M.; Marona-Lewicka, D.; Gerasimov, M.; Kurrasch-Orbaugh, D.M.; Nichols, D.E.; Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain. J Med Chem 1999, 42, 20, 4257.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(V) |
31541 |
1-[tert-butyl(dimethyl)silyl]-1H-indol-5-yl methyl ether; 1-[tert-butyl(dimethyl)silyl]-5-methoxy-1H-indole
|
|
C15H23NOSi |
详情 |
详情
|
(VI) |
31542 |
3-bromo-1-[tert-butyl(dimethyl)silyl]-5-methoxy-1H-indole; 3-bromo-1-[tert-butyl(dimethyl)silyl]-1H-indol-5-yl methyl ether
|
|
C15H22BrNOSi |
详情 |
详情
|
(VII) |
31538 |
methyl (2R)-1-methyl-2-pyrrolidinecarboxylate
|
|
C7H13NO2 |
详情 |
详情
|
(VIII) |
31543 |
(5-methoxy-1H-indol-3-yl)[(2R)-1-methylpyrrolidinyl]methanone
|
|
C15H18N2O2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(III) Tetrahydropyridine (II), obtained by NaBH4 reduction of the 1-benzylpyridinium salt (I), was condensed with 5-methoxyindole (III) in refluxing 50% AcOH to produce, through a biomimetic sequence, the aminoethyl carbazole compound (IV). Catalytic debenzylation of (IV) led to the primary amine (V), which was converted to the oxalic acid mono-amide (VI) upon heating with diethyl oxalate. Cyclization of amide (VI) in the presence of POCl3 under Vilsmeier conditions furnished the pyridocarbazole tetracyclic system (VII). Dehydrogenation of (VII) over Pd/C in boiling diphenyl ether led to a mixture of the desired aromatized compound (VIII) and the decarbethoxylated byproduct (IX), which were separated by column chromatography. N-Methylation of the pyrrole ring of (VIII) to give (X) was performed by using dimethyl carbonate in DMF in the presence of K2CO3 and crown ether. Reaction of ester (X) with 2-(dimethylamino)ethylamine (XI) at 115 C gave amide (XII). Finally, the desired 9-hydroxy derivative was obtained by methyl ether cleavage in (XII) employing boron tribromide. Alternatively, the title compound was obtained by demethylation of ether (X) and subsequent reaction with 2-(dimethylamino)ethylamine (XI).
【1】
Jasztold-Howorko, R.; Landras, C.; Pierré, A.; Atassi, G.; Guilbaud, N.; Kraus-Berthier, L.; Leonce, S.; Rolland, Y.; Prost, J.F.; Bisagni, E.; Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido[4, 3-b]carbazole-1-N-[(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivatives. J Med Chem 1994, 37, 15, 2445. |
【2】
Bisagni, E.; Jasztold-Howorko, R.; Atassi, G.; Pierre, A. (ADIR et Cie.); Ellipticine derivs. with antitumor activity. EP 0591058; FR 2696465; JP 1994211852; US 5498611 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59757 |
1-Benzyl-4-(2-methyl-1,3-dioxolan-2-yl)pyridinium
|
|
C16H18NO2 |
详情 |
详情
|
(II) |
59758 |
1-benzyl-4-(2-methyl-1,3-dioxolan-2-yl)-1,2,3,6-tetrahydropyridine
|
|
C16H21NO2 |
详情 |
详情
|
(III) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(IV) |
59759 |
N-benzyl-2-(6-methoxy-1-methyl-9H-carbazol-2-yl)-1-ethanamine; N-benzyl-N-[2-(6-methoxy-1-methyl-9H-carbazol-2-yl)ethyl]amine
|
|
C23H24N2O |
详情 |
详情
|
(V) |
59760 |
2-(6-methoxy-1-methyl-9H-carbazol-2-yl)-1-ethanamine; 2-(6-methoxy-1-methyl-9H-carbazol-2-yl)ethylamine
|
|
C16H18N2O |
详情 |
详情
|
(VI) |
59761 |
ethyl 2-{[2-(6-methoxy-1-methyl-9H-carbazol-2-yl)ethyl]amino}-2-oxoacetate
|
|
C20H22N2O4 |
详情 |
详情
|
(VII) |
59762 |
ethyl 9-methoxy-5-methyl-4,6-dihydro-3H-pyrido[4,3-b]carbazole-1-carboxylate
|
|
C20H20N2O3 |
详情 |
详情
|
(VIII) |
59764 |
ethyl 9-methoxy-5-methyl-6H-pyrido[4,3-b]carbazole-1-carboxylate
|
|
C20H18N2O3 |
详情 |
详情
|
(IX) |
59763 |
methyl 5-methyl-6H-pyrido[4,3-b]carbazol-9-yl ether; 9-methoxy-5-methyl-6H-pyrido[4,3-b]carbazole
|
|
C17H14N2O |
详情 |
详情
|
(X) |
59765 |
ethyl 9-methoxy-5,6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylate
|
|
C21H20N2O3 |
详情 |
详情
|
(XI) |
14881 |
N-(2-aminoethyl)-N,N-dimethylamine; N(1),N(1)-dimethyl-1,2-ethanediamine; 2-Dimethylaminoethylamine
|
108-00-9 |
C4H12N2 |
详情 | 详情
|
(XII) |
59766 |
N-[2-(dimethylamino)ethyl]-9-methoxy-5,6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxamide
|
|
C23H26N4O2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) The cyclization of 5-methoxy-1H-indole (I) with hexane-2,6-dione (II) by means of BF3 ethearate in refluxing dioxane gives 6-methoxy-1,4-dimethylcarbazole (III), which is formylated with N-methylformanilide (IV) and POCl3 in hot o-dichlorobenzene yielding the 3-formyl derivative (V). The condensation of (V) with 2-aminoacetaldehyde diethylacetal (VI) by heating at 100 C affords the expected imino derivative (VII), which is cyclized by acid (HCl) hydrolysis of the acetal group and cyclization of the resulting aldehyde by means of NaOH in water to the 9-methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole (VIII). The oxidation of (VIII) with m-chloroperbenzoic acid (MCPBA) in acetone gives the correponding N-oxide (IX), which is treated with BBr3 in dichloromethane yielding 9-hydroxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole (X). Finally, this compound is treated with 1-bromo-3-methoxy-2-propanone in DMF to afford the desired quaternary salt.
【1】
Liu, Q.-R.; et al.; Aust J Chem 1967, 20, 2715.
|
【2】
Harada, N.; et al.; Synthesis and antitumor activity of quaternary salts of 2-(2'-oxoalkoxy)-9-hydroxyellipticines. Chem Pharm Bull 1997, 45, 1, 134.
|
【3】
Guthrie, R.W.; et al.; Ellipticine derivatives. J Med Chem 1975, 18, 7, 755.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
24848 |
acetonyl acetone;1,2-Diacetylethane;a,b-Diacetylethane;2,5-Diketohexane;Diacetonyl;Acetonylacetone;2,5-Dioxohexane;2,5-hexanedione |
110-13-4 |
C6H10O2 |
详情 | 详情
|
(III) |
19938 |
5,8-dimethyl-9H-carbazol-3-yl methyl ether; 6-methoxy-1,4-dimethyl-9H-carbazole
|
|
C15H15NO |
详情 |
详情
|
(IV) |
20360 |
methyl(phenyl)formamide;N-Methylformanilide;N-Formyl-N-methylaniline;Methylphenylformamide;N-methyl-N-phenylformamide;N-Methyl-N-formylaniline;N-Formyl-N-methylaniline |
93-61-8 |
C8H9NO |
详情 | 详情
|
(V) |
27052 |
6-methoxy-1,4-dimethyl-9H-carbazole-3-carbaldehyde
|
|
C16H15NO2 |
详情 |
详情
|
(VI) |
10331 |
2,2-Diethoxy-1-ethanamine; 2,2-Diethoxyethylamine; Aminoacetaldehyde diethyl acetal
|
645-36-3 |
C6H15NO2 |
详情 | 详情
|
(VII) |
27053 |
1-ethoxy-2-[[(Z)-(6-methoxy-1,4-dimethyl-9H-carbazol-3-yl)methylidene]amino]-1-ethanol
|
|
C20H24N2O3 |
详情 |
详情
|
(VIII) |
27054 |
9-methoxy-1,4,5,11-tetramethyl-6H-pyrido[4,3-b]carbazole
|
|
C20H20N2O |
详情 |
详情
|
(IX) |
27055 |
9-methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazol-2-ium-2-olate
|
|
C18H16N2O2 |
详情 |
详情
|
(X) |
27056 |
9-hydroxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazol-2-ium-2-olate
|
|
C17H14N2O2 |
详情 |
详情
|
(XI) |
27057 |
1-bromo-3-methoxyacetone
|
|
C4H7BrO2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) The hydrogenation of 5-methoxy-1H-indole (I) by means of NaCNBH3 in acetic acid gives 5-methoxyindoline (II), which is benzoylated with benzonitrile (III) by means of BCl3/AlCl3 in dichloroethane yielding 7-benzoyl-5-methoxyindoline (IV). The cyclization of (IV) with glycine ethyl ester (V) in pyridine affords the pyrrolo[1,4]benzodiazepine (VI), which is treated with amyl nitrite in toluene/THF to provide the oxime (VII). The reduction of (VII) with H2 over Ru/C in methanol gives the racemic amine (VIII), which is submitted to optical resolution with di-p-toluoyl-D-tartaric acid yielding the corresponding (R)-isomer (IX). Finally, this compound is condensed with 1H-indole-2-carboxylic acid (X) by means of TOTU and DIEA in dichloromethane.
【1】
Feru, F.; et al.; Synthesis and structure-activity relationships of 9-methoxy-4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indolines: Novel PDE 4 inhibitors. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 049.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
40665 |
cyclopentyl nitrite
|
|
C5H9NO2 |
详情 |
详情
|
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
25903 |
5-methoxyindoline; 2,3-dihydro-1H-indol-5-yl methyl ether
|
|
C9H11NO |
详情 |
详情
|
(III) |
25904 |
benzonitrile
|
100-47-0 |
C7H5N |
详情 | 详情
|
(IV) |
25905 |
(5-methoxy-2,3-dihydro-1H-indol-7-yl)(phenyl)methanone
|
|
C16H15NO2 |
详情 |
详情
|
(V) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(VI) |
25906 |
9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C18H16N2O2 |
详情 |
详情
|
(VII) |
25907 |
9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indole-3,4-dione 3-oxime
|
|
C18H15N3O3 |
详情 |
详情
|
(VIII) |
25908 |
3-amino-9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C18H17N3O2 |
详情 |
详情
|
(IX) |
25909 |
(3R)-3-amino-9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C18H17N3O2 |
详情 |
详情
|
(X) |
25226 |
1H-Indole-2-carboxylic acid; Indole-2-carboxylic acid
|
1477-50-5 |
C9H7NO2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The reaction of 5-methoxyindol (I) with 4-fluorobenzyl chloride in DMF gives 5-methoxy-1-(4-fluorobenzyl)indol (II). This compound is acylated with oxalyl chloride, yielding 5-methoxy-[1-(4-fluorobenzyl)indol-3-yl]glyoxylic acid chloride (III), which is transformed with 4-amino-3,5-dichloropyridine into the corresponding amide (IV). The reaction of (IV) with borontribromide in toluene cleaves the methoxy group, yielding AWD 12-281.
【1】
Hofgen, N.; Schupke, H.; Marx, D.; Gasparic, A.; Kronbach, T.; Hartenhauer, H.; Szelenyi, I.; Krone, D.; Hempel, R.; Kiss, H.; Berthold, K.; Egerland, U.; Olbrich, M.; Heer, S.; Rundfelt, C.; AWD 12-281. Drugs Fut 2002, 27, 2, 111.
|
【2】
Höfgen, N.; Kronbach, T.; Plymeropoulos, E.; Marx, D.; Heer, S.; Szelenyi, S.; Egerland, U.; Poppe, H. (Arzneimittelwerk Dresden GmbH); New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same. CA 2270301; DE 19818964; WO 9955696 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
12354 |
4-Fluorobenzyl chloride; 1-(Chloromethyl)-4-fluorobenzene
|
352-11-4 |
C7H6ClF |
详情 | 详情
|
|
25135 |
3,5-dichloro-4-pyridinamine; 4-amino-3,5-dichloropyridine
|
22889-78-7 |
C5H4Cl2N2 |
详情 | 详情
|
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
51711 |
1-(4-fluorobenzyl)-1H-indol-5-yl methyl ether; 1-(4-fluorobenzyl)-5-methoxy-1H-indole
|
|
C16H14FNO |
详情 |
详情
|
(III) |
51712 |
2-[1-(4-fluorobenzyl)-5-methoxy-1H-indol-3-yl]-2-oxoacetyl chloride
|
|
C18H13ClFNO3 |
详情 |
详情
|
(IV) |
31732 |
N-(3,5-dichloro-4-pyridinyl)-2-[1-(4-fluorobenzyl)-5-methoxy-1H-indol-3-yl]-2-oxoacetamide
|
|
C23H16Cl2FN3O3 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) Protection of 5-methoxyindole (I) with benzenesulfonyl chloride (II) in the presence of NaH affords the N-sulfonyl indole (III). Acylation of the 2-lithio derivative of (III) with benzoyl chloride (IV) gives rise to ketone (V). Finally, removal of the phenylsulfonyl protecting group of (V) is achieved by either basic hydrolysis or by treatment with tetrabutylammonium fluoride.
【1】
Hufsky, H.; Pongratz, H.; Mahboobi, S.; et al.; Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem 2001, 44, 26, 4535.
|
【2】
Teller, S.; Pongratz, H.; Mahboobi, S.; et al.; Bis(1H-2-indolyl) methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase. J Med Chem 2002, 45, 5, 1002.
|
【3】
Burger, A.; Mahboobi, S.; Pongratz, H.; Hufsky, H.; Böhmer, F.-D.; Beckers, T.; Klenner, T.; Baasner, S.; Frieser, M.; Hockemeyer, J.; Fiebig, H.-H. (Asta Medica AG); 2-Acyl indol derivs. and their use as anti-tumour agents. DE 10020852; WO 0182909 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
14713 |
benzenesulfonyl chloride
|
98-09-9 |
C6H5ClO2S |
详情 | 详情
|
(III) |
57928 |
5-methoxy-1-(phenylsulfonyl)-1H-indole; methyl 1-(phenylsulfonyl)-1H-indol-5-yl ether
|
|
C15H13NO3S |
详情 |
详情
|
(IV) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(V) |
57929 |
[5-methoxy-1-(phenylsulfonyl)-1H-indol-2-yl](phenyl)methanone
|
|
C22H17NO4S |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(VIII)
【1】
Buchheit KH, Gamse R, Giger R, et al. 1995. The serotonin 5-HT4 receptor. 2. structure-ractivity studies of the indole carbazimidamide class 0f agonists. J Med Chan, 38(13): 2331~2338 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12954 |
1-Hydrazinecarbothioamide; Thiosemicarbazide
|
79-19-6 |
CH5N3S |
详情 | 详情
|
(II) |
20318 |
methyl 1-hydrazinecarbimidothioate hydroiodide
|
|
C2H7N3S.HI |
详情 |
详情
|
(IX) |
20321 |
5-methoxy-1H-indole-3-carbaldehyde
|
10601-19-1 |
C10H9NO2 |
详情 | 详情
|
(III) |
15764 |
amylamine; 1-pentanamine; pentylamine
|
110-58-7 |
C5H13N |
详情 | 详情
|
(IV) |
20320 |
N-pentyl-1-hydrazinecarboximidamide hydroiodide
|
|
C6H16N4.HI |
详情 |
详情
|
(V) |
66763 |
3-methyl-4-nitrophenol;4-Nitro-m-cresol |
2581-34-2 |
C7H7NO3 |
详情 | 详情
|
(VI) |
66764 |
4-methoxy-2-methyl-1-nitrobenzene;3-Methyl-4-nitroanisole;5-Methoxy-2-nitrotoluene |
5367-32-8 |
C8H9NO3 |
详情 | 详情
|
(VII) |
66765 |
(E)-2-(5-methoxy-2-nitrophenyl)-N,N-dimethylethenamine |
|
C11H14N2O3 |
详情 | 详情
|
(VIII) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(II)
【1】
Ge YH. Wu YM, Xue ZJ.et al. 2004. Synthesis of 5-methoocyindole-3-carboxaldehyde. 化工时刊.18(7):24~25 |
【2】
Teng X, Degterev A, Jagtap P, et al. 2005. Structure-activity relationship study of nove necroptosis inhibitors. Bioorg Med Chem lett, 15(22) : 5039~5044 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66766 |
4-nitroanisole;1-Methoxy-4-nitrobenzene;4-Methoxy-1-nitrobenzene;4-Methoxynitrobenzene;4-Nitro-1-methoxybenzene;4-Nitroanisole;4-Nitromethoxybenzene;4-Nitrophenyl methyl ether;Methyl 4-nitrophenyl ether;Methyl p-nitrophenyl ether;p-Methoxynitrobenzene;p-Nitroanisole;p-Nitrobenzene methyl ether;p-Nitromethoxybenzene |
100-17-4 |
C7H7NO3 |
详情 | 详情
|
(II) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(III) |
20321 |
5-methoxy-1H-indole-3-carbaldehyde
|
10601-19-1 |
C10H9NO2 |
详情 | 详情
|